MedTrace Logo

Inhibitory Control and Gait Adaptability in Parkinson's Disease

NCT07494461 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-03-27

No results posted yet for this study

Summary

People with Parkinson's disease (PD) may have difficulty stopping or changing their movements, especially when walking around obstacles.

The goal of this observational study is to learn if a specific cognitive function, called inhibitory control (the ability to stop or control actions) is associated with gait adaptability in people with Parkinson's disease. Gait adaptability means the ability to adjust how a person walks in response to changes in the environment, such as stepping over obstacles.

The main questions the study aims to answer are:

* If brain activation related to inhibitory control, measured by EEG, is associated with gait adaptability during obstacle crossing in people with Parkinson's disease?
* If behavioral inhibitory control is associated with gait adaptability during obstacle crossing in people with Parkinson's disease?

Participants take part in one study visit. During this visit, participants complete simple thinking tests, have their brain activity recorded using EEG, and perform walking tasks that include stepping over obstacles.

Conditions

  • Parkinson Disease (PD)

Sponsors & Collaborators

  • National Yang Ming Chiao Tung University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2029-08-31
Completion
2029-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07494461 on ClinicalTrials.gov